Physician
Oncology
Dr. Margaret A. Tucker, MD
|
|
Give Review
Margaret Tucker practices Oncology. She went to medical school at Harvard Medical School. Harvard Medical School is one of the top medical schools in the US. Harvard Medical School is ranked 1 in research and 12 in primary care medicine Margaret Tucker is a published MD. She published 100 publications, including: 'Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members ofMelanoma Families.'
Publications
- Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women.
- Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families.
- Lung cancer prognosis before and after recurrence in a population-based setting.
- Histologic features of melanoma associated with CDKN2A genotype.
- Characterization of large structural genetic mosaicism in human autosomes.
- Depression Outcomes Associated With an Intervention Implemented in Employment Training Programs for Low-Income Adolescents and Young Adults.
- Genome-wide Scan of 29,141 African Americans Finds No Evidence of Directional Selection since Admixture.
- Risk of Subsequent Malignant Neoplasms in Long-Term Hereditary Retinoblastoma Survivors After Chemotherapy and Radiotherapy.
- Genetic polymorphisms in the 9p21 region associated with risk of multiple cancers.
- Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations.
- Imputation and subset based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33.
- Constitutional promoter methylation and risk of familial melanoma.
- Breast cancer risk after radiotherapy for heritable and non-heritable retinoblastoma: a US-UK study.
- Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.
- The Age-Specific Effect Modification of Male Sex for Ulcerated Cutaneous Melanoma.
- Retinoblastoma Incidence Patterns in the US Surveillance, Epidemiology, and End Results Program.
- Genetic variants in fas signaling pathway genes and risk of gastric cancer.
- Genome-wide association study identifies two susceptibility loci for osteosarcoma.
- Association of Genetic Variants in CDK6 and XRCC1 with The Risk of Dysplastic Nevi in Melanoma-Prone Families.
- Dysplastic nevi and melanoma.
- A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry.
- Common single nucleotide polymorphisms in genes related to immune function and risk of papillary thyroid cancer.
- Genetic variants in DNA repair pathway genes and risk of esophageal squamous cell carcinoma and gastric adenocarcinoma in a Chinese population.
- Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008.
- On the interplay of telomeres, nevi and the risk of melanoma.
- Common genetic variants in the 9p21 region and their associations with multiple tumours.
- Absolute risk prediction of second primary thyroid cancer among 5-year survivors of childhood cancer.
- The association between cancer and amyotrophic lateral sclerosis.
- LINE-1 methylation in peripheral blood and the risk of melanoma in melanoma-prone families with and without CDKN2A mutations.
- Authors' response to: Qualitative Job-Exposure Matrix--a tool for the quantification of population attributable fractions for occupational lung carcinogens?
- Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia.
- A Pooled Analysis of Thyroid Cancer Incidence Following Radiotherapy for Childhood Cancer.
- Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies.
- Genetic variant in TP63 on locus 3q28 is associated with risk of lung adenocarcinoma among never-smoking females in Asia.
- Duplication of CXC chemokine genes on chromosome 4q13 in a melanoma-prone family.
- Common Genetic Variants in Sex Hormone Pathway Genes and Papillary Thyroid Cancer Risk.
- The chromosome 2p21 region harbors a complex genetic architecture for association with risk for renal cell carcinoma.
- High-risk pregnancy and neonatal complications in the DNA repair and transcription disorder trichothiodystrophy: report of 27 affected pregnancies.
- Genetic variants in DNA repair genes and the risk of cutaneous malignant melanoma in melanoma-prone families with/without CDKN2A mutations.
- Common genetic variants related to genomic integrity and risk of papillary thyroid cancer.
- Sunbeds and sunlamps: who used them and their risk for melanoma.
- Lack of germline PALB2 mutations in melanoma-prone families with CDKN2A mutations and pancreatic cancer.
- A flexible multiplex bead-based assay for detecting germline CDKN2A and CDK4 variants in melanoma-prone kindreds.
- Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype.
- Hereditary genodermatoses with cancer predisposition.
- Rising melanoma incidence rates of the trunk among younger women in the United States.
- A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma.
- Increased risk of second primary cancers after a diagnosis of melanoma.
- MicroRNA expression differentiates histology and predicts survival of lung cancer.
- Alcohol consumption and lung cancer risk in the Environment and Genetics in Lung Cancer Etiology (EAGLE) study.
- Identification of modifier genes for cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations.
- Risk of cataract extraction among adult retinoblastoma survivors.
- A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma.
- Selection criteria for genetic assessment of patients with familial melanoma.
- Divergent cancer pathways for early-onset and late-onset cutaneous malignant melanoma.
- Family history of cancer and nonmalignant lung diseases as risk factors for lung cancer.
- Melanoma epidemiology.
- Cause-specific mortality in long-term survivors of retinoblastoma.
- Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005.
- Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression.
- Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer.
- Recent trends in incidence of cutaneous melanoma among US Caucasian young adults.
- Cancer screening practices of adult survivors of retinoblastoma at risk of second cancers.
- Two newly identified genetic determinants of pigmentation in Europeans.
- ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma.
- Is sunlight important to melanoma causation?
- Genetic testing for melanoma predisposition: current challenges.
- Long-term evaluation of three multiple-case Waldenstrom macroglobulinemia families.
- Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries.
- Sun exposure measurements in populations.
- Reproductive risk factors for cutaneous melanoma in women: a case-control study.
- Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma.
- Genomewide linkage screen for Waldenstrom macroglobulinemia susceptibility loci in high-risk families.
- Making sense of puzzling genetic association studies: a team approach.
- Tobacco use in adult long-term survivors of retinoblastoma.
- Identifying individuals at high risk of melanoma: a practical predictor of absolute risk.
- Recent tanning bed use: a risk factor for melanoma.
- Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations.
- Re: Sun exposure and mortality from melanoma.
- A piece of the melanoma puzzle.
- Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations.
- Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database.
- Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up.
- Cytogenetics of familial Waldenstrom's macroglobulinemia: in pursuit of an understanding of genetic predisposition.
- Breast cancer risks for BRCA1/2 carriers.
- Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control study.
- Diet and melanoma in a case-control study.
- Re: "Childhood cancer and population mixing".
- Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among e...
- Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study.
- Average midrange ultraviolet radiation flux and time outdoors predict melanoma risk.
- Analysis of mutations and identification of several polymorphisms in the putative promoter region of the P34CDC2-related CDC2L1 gene located at 1P36 in melanoma cell l...
- A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families.
- Breast cancer risk in Ashkenazi BRCA1/2 mutation carriers: effects of reproductive history.
- DNA repair, dysplastic nevi, and sunlight sensitivity in the development of cutaneous malignant melanoma.
- HLA-DR, HLA-DQ, and TAP genes in familial Hodgkin disease.
- Genetic variants in epidermal growth factor receptor pathway genes and risk of esophageal squamous cell carcinoma and gastric cancer in a chinese population.
- Characterizing the genetic basis of methylome diversity in histologically normal human lung tissue.
- Telomere Length and the Risk of Cutaneous Malignant Melanoma in Melanoma-Prone Families with and without CDKN2A Mutations.
Schools
Harvard Medical School
Stanford University Med Center
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Stanford University -
Harvard Medical School
Helpful Reviews
Similar Doctors
|
|
Jacqueline P. Whang |
|
|
Dr. Kevin K. Tay, MD |
|
|
Dr. George A. Sotos, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neil E. Caporaso, MD |
|
|
Dr. Chitra D. Rajagopal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Manish Agrawal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph M. Haggerty, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ibilola A. Fashoyin-Aje, MD
This Doctor is OpenDoctor Recommended.
|